Breast Cancer Care: Many Gaps Remain, Says Audit Office
- France's breast cancer care system, encompassing screening, treatment, and follow-up care, faces significant shortcomings and disparities in access, according to recent reports.
- Breast cancer screening in France is not universally accessible,leading to inequalities in early detection.
- the Institut National du Cancer (INCa) reported in its 2023 evaluation of organized breast cancer screening that participation rates ranged from 44.1% to 65.8% across different regions.
Breast Cancer Care in France: Gaps and Inequalities
Table of Contents
France’s breast cancer care system, encompassing screening, treatment, and follow-up care, faces significant shortcomings and disparities in access, according to recent reports. These issues impact patient outcomes and highlight the need for systemic improvements.
Screening Disparities
Breast cancer screening in France is not universally accessible,leading to inequalities in early detection. While national guidelines recommend mammography screening for women aged 50 to 74, participation rates vary significantly by region and socioeconomic status. Women in rural areas and those with lower incomes are less likely to be screened regularly.
the Institut National du Cancer (INCa) reported in its 2023 evaluation of organized breast cancer screening that participation rates ranged from 44.1% to 65.8% across different regions. This disparity directly impacts the stage at which cancers are diagnosed, with later diagnoses generally leading to poorer prognoses.
Treatment Access and Regional Variations
Access to specialized breast cancer treatment centers and innovative therapies also varies across france. Patients in certain regions may face longer wait times for appointments with oncologists or limited access to clinical trials. The availability of reconstructive surgery following mastectomy differs considerably between hospitals.
A 2022 report by the Haute Autorité de Santé (HAS) highlighted these regional variations in access to care, specifically noting differences in the implementation of multidisciplinary breast cancer meetings - crucial for coordinating patient treatment plans. The report is available here. The HAS recommends standardized protocols and increased collaboration between healthcare facilities to address these inequalities.
Post-Cancer Care and Support
Follow-up care and support for breast cancer survivors are often inadequate. Many patients report a lack of details about long-term side effects of treatment, psychological support services, and rehabilitation programs. This gap in care can significantly impact quality of life and contribute to late effects.
The Ligue contre le cancer, France’s leading cancer charity, has consistently advocated for improved post-cancer care pathways. In a February 2023 statement, they called for the development of personalized follow-up plans and increased funding for support services. They cite a 2021 survey showing that 40% of breast cancer survivors feel insufficiently supported after treatment.
Legislative and Regulatory Framework
France’s national cancer plan, Plan Cancer, aims to address these challenges.The current Plan Cancer 2023-2027, announced by President Macron, allocates €1.7 billion to improve cancer prevention, screening, diagnosis, and treatment. A detailed overview of the plan is available on the Ministry of Health’s website.
Key provisions of the plan include increasing screening rates, reducing regional disparities in access to care, and strengthening support for cancer survivors. However, critics argue that the plan lacks specific targets and measurable outcomes, making it difficult to assess its effectiveness. The Cour des Comptes (French Court of Auditors) is expected to publish an evaluation of the plan’s implementation in late 2026.